Drug Shortage Report for TEVA-VALGANCICLOVIR

Last updated on 2018-03-13 History
Report ID 18033
Drug Identification Number 02413825
Brand name TEVA-VALGANCICLOVIR
Common or Proper name VALGANCICLOVIR
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VALGANCICLOVIR
Strength(s) 450MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60
ATC code J05AB
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-08-01
Estimated end date 2018-02-16
Actual end date 2018-02-28
Shortage status Resolved
Updated date 2018-03-13
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-03-13 French Compare
v9 2018-03-13 English Compare
v8 2017-10-10 French Compare
v7 2017-10-10 English Compare
v6 2017-10-10 English Compare
v5 2017-09-19 French Compare
v4 2017-09-19 English Compare
v3 2017-08-02 French Compare
v2 2017-08-02 English Compare
v1 2017-08-02 English Compare